ALTSTATION.IO

Kimberly-Clark Corporation (KMB) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$104.48

Change

+0.21%

Market Cap

$34.68B

Avg Volume

6.2M

Company Overview

Kimberly-Clark Corporation (KMB) manufactures and markets a broad range of personal care and household products. Headquartered in Dallas, Texas, the company operates through three main segments: North America, International Personal Care, and International Family Care and Professional. Their product lineup includes well-known brands like Huggies, Kotex, Kleenex, and Scott, covering categories such as disposable diapers, feminine hygiene products, and household tissue and towels. Their customers range from individual consumers to large retailers, e-commerce platforms, and professional sectors.

As a market leader in the consumer defensive sector, Kimberly-Clark holds a robust position against key competitors like Procter & Gamble and Unicharm. Their extensive brand portfolio and deep distribution channels give them a competitive edge. However, they face threats from rising raw material costs and evolving consumer preferences, with eco-friendly products gaining traction. Additionally, economic pressures can impact discretionary spending, which could affect sales of non-essential goods.

Currently, Kimberly-Clark is navigating challenges with a focus on sustainability and innovation. The company has introduced initiatives to reduce its environmental footprint and is investing in new product development to address changing consumer demands. While they have seen some fluctuations in revenue due to market conditions, their strong brand loyalty and commitment to adapting to trends position them for steady growth in the long term.

Key Financials

Market Cap

$34.68B

Revenue

$16.45B

EBITDA

$3.37B

Gross Margin

37.3%

Profit Margin

12.3%

Revenue Growth

-17.2%

Total Cash

$688.00M

Total Debt

$7.19B

Free Cash Flow

$1.13B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

21.50

Forward P/E

13.54

Beta

0.28

52-Week High

$150.45

52-Week Low

$96.26

EPS

$4.86

50-Day Avg

$101.79

200-Day Avg

$120.62

Price/Book

23.09

Technical Analysis

The overall trend for Kimberly-Clark Corporation (KMB) over the past 52 weeks is clearly bearish, with a decline of 17.4%. The stock peaked around $144 in February before experiencing a sustained downward trend, reflected by lower highs and lower lows. Key resistance is identified at the $130 level, where the stock faced multiple rejections from February through October, while a significant support level is seen near the $100 mark, with recent price action testing this area. The chart also indicates a possible consolidation phase in the last few weeks, with the price hovering around $104.48, just above the support level of $104.33 established in January. This positioning suggests that the current price is near the lower end of the 52-week range, reinforcing potential weakness. If the support holds, it could set the stage for either a reversal or further consolidation before any significant recovery.

Recent News and Developments

Market Update

Here’s a summary of the latest news and developments for Kimberly-Clark Corporation (KMB) stock in the past week:

1. Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Acquisition

Shareholders of both Kimberly-Clark and Kenvue have overwhelmingly approved the stock issuance and merger agreement for Kimberly-Clark’s acquisition of Kenvue. This marks a significant regulatory and transactional milestone, with approximately 96% of KMB shares present and 99% of Kenvue votes cast in favor of the deal. The acquisition is still subject to regulatory approvals and other customary closing conditions, with an expected completion in the second half of 2026.

2. Q4 2025 Earnings Beat on EPS, Mixed Revenue Reaction

Kimberly-Clark reported Q4 2025 earnings per share (EPS) of $1.86, surpassing the consensus estimate of $1.81. While the company achieved a 2.76% EPS beat, revenue of $4.08 billion slightly missed analysts’ expectations of $4.09 billion. Following the earnings announcement, KMB’s stock experienced a 1.58% decline in pre-market trading, settling at $99.54, reflecting a mixed market reaction to the EPS beat and revenue miss.

Market Sentiment and Analyst Recommendations

Bull Case

The Kenvue acquisition is a legitimate strategic play that addresses KMB’s core weakness: consumer health exposure. Shareholders approved it with 96% support, and closing in H2 2026 adds a $4.8B revenue stream in a defensive category that’s holding up better than tissue. The Q4 EPS beat of $1.86 versus $1.81 consensus shows operational discipline despite the revenue miss, and management highlighted steady volume gains and market share wins. At 21.50 P/E with $688M cash against $7.19B debt, the multiple is reasonable for a staple company, especially if Kenvue integration drives margin recovery as promised. The insider buy by Director Maclin signals confidence from the boardroom. Analyst consensus target of $118.71 represents 13.6% upside from current levels, and if the stock holds the $100 support, a reversal to $130 resistance is plausible.

Bear Case

Revenue contracted 17.2% year-over-year, which is a brutal number for a company that’s supposed to be defensive. The stock is down 18.9% over the past year and trading at the lower end of its 52-week range, suggesting the market has already priced in serious concerns. The Kenvue deal won’t close until H2 2026, meaning execution risk and integration uncertainty will hang over the stock for at least a year. Management admitted to promotional pressure in North America and loss of club-channel diaper distribution, both margin headwinds that don’t reverse quickly. At $104.48, KMB is only 12.5% above its 52-week low, and the chart shows lower highs and lower lows — textbook weakness. The debt load of $7.19B is substantial relative to the $688M cash position, limiting financial flexibility during the integration period.

What to Watch

Monitor the Kenvue deal for regulatory approval updates in Q2 and Q3 2026; any delays or conditions would signal execution risk. Track Q1 2026 earnings for signs of stabilization in North America volume and pricing power after the promotional pressure mentioned on the earnings call. Watch whether KMB holds the $100 support level; a break below that opens the door to $96 and the bottom of the 52-week range. Listen for updates on margin recovery initiatives and productivity gains — management promised margin expansion but needs to prove it with actual results. Follow analyst price target revisions closely; Bank of America already cut its outlook due to multiple compression, so consensus could shift lower if the market reprices consumer staples. Finally, track insider buying patterns; Maclin’s $38K purchase is a small signal, but sustained insider accumulation would validate confidence in the turnaround thesis.

Analyst Consensus

HOLD

Based on 14 analyst opinions

Low Target

$90.00

Mean Target

$118.71

High Target

$162.00

Earnings and Financial Data

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

N/A

Earnings & Dividends

Next Earnings

Apr 21, 2026

EPS (Trailing)

$4.86

Dividend Yield

491.0%

Payout Ratio

103.7%

Frequently Asked Questions

Is KMB a good stock to buy?

Kimberly-Clark (KMB) is currently rated as a HOLD by analysts with a target price of $118.71, suggesting limited upside from its current price of $104.48. The stock has a solid P/E ratio of 21.50, but the stagnation in its share price within a 52-week range of $96.26 to $150.45 makes it less attractive in the short term.

What is KMB’s price target?

Analysts have set a price target for Kimberly-Clark at $118.71. Given the stock’s current price of $104.48, this represents an upside potential of about 13.6%, which may not be enough to entice high-risk investors.

Does KMB pay a dividend?

Yes, Kimberly-Clark offers a substantial dividend yield of 491.0%. This makes it appealing to income-focused investors, though it’s essential to consider the sustainability of such a high yield in the context of future earnings.

What is KMB’s market capitalization?

Kimberly-Clark has a market capitalization of approximately $34.68 billion. This positions the company as a sizable player in the consumer defensive sector, indicating stability but also less agility compared to smaller competitors.

How does KMB’s forward P/E compare to its current P/E?

KMB’s forward P/E is 13.54, which significantly lower than its current P/E of 21.50. This suggests that analysts expect stronger earnings growth in the future, but the current valuation may still appear rich given the company’s recent performance.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.